XML 78 R58.htm IDEA: XBRL DOCUMENT v3.22.0.1
NET EARNINGS (LOSS) PER SHARE (Details) - shares
12 Months Ended
Jul. 10, 2014
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Common shares outstanding, basic:        
Weighted average common shares outstanding-basic   42,060,996 41,907,597 41,762,893
Common shares outstanding, diluted:        
Weighted average common shares outstanding-basic   42,060,996 41,907,597 41,762,893
Weighted-average common shares outstanding, diluted (in shares)   42,588,871 41,907,597 41,762,893
Restricted Stock Units        
Anti-dilutive shares (in shares)     298,834 162,096
Stock Options        
Anti-dilutive shares (in shares)     837,338 496,148
New Genco Equity Warrants        
Anti-dilutive shares (in shares)   3,936,761 3,936,761 3,936,761
New Genco Equity Warrants        
Equity warrant term 7 years      
Number of shares of new stock in which each warrant or right can be converted 0.10      
Stock Options        
Common shares outstanding, diluted:        
Dilutive effect of sharebased arrangements   313,684    
Restricted Stock Units        
Common shares outstanding, diluted:        
Dilutive effect of sharebased arrangements   214,191